CAMP and rosacea: Paeoniflorin, a monoterpenoid glycoside with various pharmacological activities, can alleviate rosacea-like inflammatory response by inducing suppressor of cytokine signaling 3 expression and suppressing the LPS-induced upregulation of TLR-2 and LL-37 via the ASK1-p38 cascade in macrophages (96).